|
Cancer Center Support Grant
|
5P30CA013696-38
|
$3,816,425
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-08
|
$216,434
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
NANO-DELIVERY OF MITOCHONDRIA-SPECIFIC CERAMIDE TO OVERCOME TUMOR DRUG RESISTANCE
|
5R21CA135594-02
|
$196,840
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
SPORE in Breast Cancer
|
5P50CA098131-09
|
$2,185,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY
|
|
Image-guided combination therapy: noninvasive assessment of delivery and response
|
1R01CA154738-01
|
$608,757
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-25
|
$2,133,222
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-13
|
$95,412
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-08
|
$1
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
Explosive Evolution Under Stress: The Driving Forces of Cancer Dynamics (Main)
|
5U54CA143803-03
|
$2,838,090
|
Austin, Robert
|
PRINCETON UNIVERSITY
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-37
|
$386,252
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cysteine Protease Network in Tumor Progression and Therapy
|
5R01CA127535-05
|
$349,249
|
BACCALA, ROBERTO
|
SCRIPPS RESEARCH INSTITUTE
|
|
ENGINEERED INTELLIGENT MICELLE FOR TUMOR pH TARGETING
|
5R01CA101850-07
|
$263,045
|
Bae, You
|
UNIVERSITY OF UTAH
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-21
|
$417,931
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-32S1
|
$665,444
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-32
|
$8,893,886
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-27
|
$2,878,195
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
WUMC Cancer and Leukemia Group B
|
5U10CA077440-14
|
$330,937
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-12
|
$2,117,925
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Clinical Studies to Circumvent Drug Resistance
|
ZIA BC 010620
|
$87,290
|
Bates, Susan
|
CCR (NCI)
|
|
Novel deregulated genes in the etiology and progression of human prostate cancer
|
5R01CA138791-02
|
$358,242
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-27
|
$1,400,911
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
The Gulf Coast MBCCOP
|
5U10CA128536-05
|
$484,872
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
5U10CA035101-26
|
$822,579
|
Behrens, Robert
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
ECOG Clinical Trials
|
5U10CA017145-36
|
$415,756
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
CANCER CENTER SUPPORT GRANT
|
2P30CA022453-29
|
$2,553,798
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-29S1
|
$50,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-29S2
|
$75,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-29S3
|
$140,000
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-18
|
$542,939
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-23
|
$340,836
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Cancer and Leukemia Group B
|
3U10CA031946-30S1
|
$3,449,605
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B
|
5U10CA031946-30
|
$10,820,362
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer and Leukemia Group B CCOP Research Base
|
5U10CA037447-27
|
$2,389,751
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-02
|
$188,304
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER
|
5U10CA037517-27
|
$4,573,089
|
BLESSING, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-14
|
$462,357
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
PROSTATE CANCER STEM CELL-TARGETED ACTIVITY OF A NEW-GENERATION TAXOIDS
|
5R21CA150085-02
|
$165,616
|
Botchkina, Galina
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Transport of Large Molecules and Viral Vectors in Tumors: Effects of Cytotoxic an
|
5R01CA098706-08
|
$278,762
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
ZIA SC 006353
|
$812,898
|
Brechbiel, Martin
|
CCR (NCI)
|
|
Community Clinical Oncology Program
|
5U10CA037422-24
|
$4,282,002
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
North Central Cancer Treatment Group
|
3U10CA025224-32S1
|
$1,347,651
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
North Central Cancer Treatment Group
|
5U10CA025224-32
|
$5,018,658
|
BUCKNER, JAN
|
MAYO CLINIC
|
|
Cancer and Leukemia Group B
|
5U10CA032291-30
|
$469,660
|
Burstein, Harold
|
DANA-FARBER CANCER INSTITUTE
|
|
Innate Immunity: Elucidation and Modulation for Cancer Therapy
|
5P01CA095426-10
|
$2,012,576
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
SPORE in Lung Cancer
|
5P50CA090949-10
|
$2,185,000
|
CARBONE, DAVID
|
VANDERBILT UNIVERSITY
|
|
Ozark Health Ventures, LLC dba Cancer Research for the Ozarks
|
5U10CA045560-23
|
$589,085
|
Carolla, Robert
|
OZARK HEALTH VENTURES, LLC
|
|
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
|
7R01CA138197-04
|
$446,311
|
CHANG, JENNY
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence
|
5R01CA143296-02
|
$322,040
|
CHODOSH, LEWIS
|
UNIVERSITY OF PENNSYLVANIA
|
|
In Vivo Cancer Therapy Monitoring with Diffuse Optical Methods
|
4R00CA126187-03
|
$241,532
|
CHOE, REGINE
|
UNIVERSITY OF ROCHESTER
|
|
TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER
|
5R01CA123159-05
|
$270,405
|
COLE, DAVID
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|